Company profile
TRexBio
Decoding Human Tissue Biology to Create Revolutionary Therapeutics
- Industry
- Biotechnology Research
- Employees
- 62
- Headquarters
- South San Francisco, California
- Founded
- 2018
- LinkedIn followers
- 12,740
- Office locations
- 1
TRexBio company summary
TRexBio is a company in the Biotechnology Research industry, headquartered in South San Francisco, California, founded in 2018. On LinkedIn the company has around 62 employees and 12,740 followers. Its listed specialties include Biotechnology, T Cell Biology, Regulatory T Cell, Treg, Immunology.
What technology does TRexBio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About TRexBio
TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise. The company’s Deep Biology platform maps human tissue Treg behavior to disease processes to identify and characterize novel targets for therapeutic intervention. Our lead program TRB-061, currently in a Ph1 clinical trial for atopic dermatitis, is a novel TNFR2-selective agonist designed to activate and expand effector Tregs in the tissue and restore immune balance in inflammatory diseases. TRexBio is headquartered in South San Francisco, California. For more info, visit www.trex.bio.
Specialties
Where is TRexBio located?
TRexBio lists 1 location.
Compare companies similar to TRexBio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
TRexBio trex.bio | Biotechnology Research | 62 | 2018 | South San Francisco, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about TRexBio
What does TRexBio do?
TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise. The company’s Deep Biology platform maps human tissue Treg behavior to disease processes to identify and characterize novel targets for therapeutic intervention. Our lead program TRB-061, currently in a Ph1 clinical trial for atopic dermatitis, is a novel TNFR2-selective agonist designed to activate and expand effector Tregs in the tissue and restore immune balance in inflammatory diseases. TRexBio is headquartered in South San Francisco, California. For more info, visit www.trex.bio.
How many employees does TRexBio have?
TRexBio has around 62 employees on LinkedIn.
Where is TRexBio headquartered?
TRexBio is headquartered in South San Francisco, California.
When was TRexBio founded?
TRexBio was founded in 2018.
Build a lead list from companies like TRexBio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.